NDC 63323-393
Colistimethate 150 mg per 2 mL injection, powder, lyophilized, for solution
On the label: Fresenius Kabi, LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Melrose Park, IL, United States | Makes it | Problems found, fixed voluntarilyAug 24, 2023 · 13 inspections, 2 with FDA action |
Product details
- Generic drug
- Colistimethate: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intramuscular; intravenous
- Strength
- 150 mg per 2 mL
- Approval
- ANDA ANDA065364
- On the market since
- Dec 4, 2009
- Package NDCs
63323-393-06- Official label
- DailyMed (National Library of Medicine), updated Jan 23, 2020
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?